Clarametyx Biosciences

CEO David V. Richards spoke with Contagion_Live as part of our data progress update at #IDWeek2024, explaining how our platform could enhance antibiotic effectiveness by targeting bacterial biofilms, a significant challenge in treatment. Watch the full segment below.

Now published in Nature Portfolio! An excellent commentary on the challenge of the bacterial biofilm and the technology discovered by our scientific co-founders Drs. Lauren Bakaletz and Steve Goodman at Nationwide Children's Hospital along with collaborator Dr. John Hamilton at Rush University Medical Center. Read the full article here: https://lnkd.in/dp3tyUif

As part of our participation at #IDWeek2024, we are announcing a progress update on our trial of CMTX-101 for infections associated with cystic fibrosis (CF). Read today's release for more details. #infectiousdisease #innovation #biofilms https://lnkd.in/eKYvU-us

Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually. #VaccinesWork to reduce the threat of #AntimicrobialResistance by:  ☑️ preventing an infection before it starts  ☑️ reducing the use and overuse of antibiotics  ☑️ slowing the emergence and spread of resistant pathogens    New WHO report finds vaccines could avert deaths, reduce antibiotic doses and save money from treating resistant infections: https://bit.ly/48k06KR  

David V. Richards, Steve St. Onge and Charles McOsker are heading out to LA this week for #IDWeek2024 to connect with colleagues, partners and collaborators on novel strategies to combat #infectiousdisease. Join us for a discussion on antimicrobials in the pipeline on Friday, 8 am PT. See the full program here: https://lnkd.in/dHNhCf6 #infectiousdisease #AMR #antimicrobialresistance

Clarametyx has been selected to present as part of an antimicrobial pipeline session during IDWeek, which starts October 16th. We are eager to connect with experts across the global infectious disease community to discuss the challenge of bacterial #biofilms and our innovative approach to addressing antimicrobial resistance. Join us in Los Angeles! #IDWeek2024 #infectiousdisease #AMR #antimicrobialresistance https://lnkd.in/ebwyYDnQ

Today, the United Nations General Assembly is meeting on #antimicrobialresistance, a critical threat to global public health. As nations discuss global solutions, the #PASTEURAct is one of several important approaches that can help address the #superbug crisis. #AMR #UNGA2024

New data published in The Lancet highlights the extreme urgency of addressing the global public health threat of #antimicrobialresistance, projecting it could be associated with nearly 40 million deaths by 2050. This is what drives our focus every day as we advance our technology targeting bacterial defenses. Our goal is to help rapidly and effectively eradicate infections, reducing the need for high-dose and repeated courses of antibiotics. See CNN's recap here: https://lnkd.in/ex2UCr8G

Join us tomorrow for the Smart Business Dealmakers 2024 Columbus Dealmakers Conference! https://lnkd.in/ecrFTct6

We are so grateful to be honored as part of the 2024 Columbus Dealmakers Conference hosted by Smart Business Dealmakers. Join us for a great session this Thursday to connect with others who are driving momentum across Central Ohio! #DealmakersColumbus #innovation #ColumbusBusiness